Generic Name:Rituximab Indications Non-Hodgkin’s Lymphoma (NHL): Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent. Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to a Rituxim product in combination with chemotherapy, as single-agent maintenance therapy. Non-progressing (including stable […]